<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2025-07-02 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled "Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment." The purpose of this guidance is to assist sponsors in the clinical development of drug and biological products for the treatment of the myelodysplastic syndromes (MDS). Specifically, this guidance addresses FDA's current thinking regarding the overall development program and clinical tria...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2025-12297</p>
    <p><strong>Publication Date:</strong> 2025-07-02</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/07/02/2025-12297/myelodysplastic-syndromes-developing-drug-and-biological-products-for-treatment-draft-guidance-for">https://www.federalregister.gov/documents/2025/07/02/2025-12297/myelodysplastic-syndromes-developing-drug-and-biological-products-for-treatment-draft-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-12297</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
